EU regulator gives green light for J&J to resume vaccine shipments
20 April 2021 - 19:30
Johnson & Johnson (J&J) will restart deliveries of its Covid-19 vaccine to the EU after the bloc’s drug regulator said the benefits of the shot outweigh the risks of a possible link with cases of rare blood clots.
The European Medicines Agency assessment on Tuesday echoed its review of the vaccine from AstraZeneca, which has also been linked with the rare clot. In both cases, the regulator noted that Covid-19 can be fatal and the use of vaccines is crucial to fighting the virus...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.